<PAGE> 1
--------------------------------
OMB APPROVAL
--------------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response........ 14.90
--------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
------------------
UroQuest Medical Corporation
- --------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock, par value $0.001
- --------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
917285 10 8
- --------------------------------------------------------------------------------
(CUSIP NUMBER)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing of this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 Pages
<PAGE> 2
CUSIP NO. 917285 10 8 13G PAGE 2 OF 5 PAGES
--------------------- ----- -----
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Richard C. Davis
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
DE
---------------------------------------------------------------------
(5) SOLE VOTING POWER
NUMBER OF 1,078,715
SHARES --------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
OWNED BY
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH 1,078,715
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
--------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,078,715
---------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.02%
---------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
IN
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 3
CUSIP No. 917285 10 8 Page 3 of 5 Pages
Item 1.
(a) Name of Issuer: UroQuest Medical Corporation (the "Issuer")
(b) Address of Issuer's Principal
Executive Offices: 173 Constitution Drive,
Menlo Park, CA 94025
Item 2.
(a) Name of Person Filing: Richard C. Davis
(b) Address of Principal Business Office or, if none. Residence: The
business address of Richard C. Davis is 7650 Courtney Campbell
Causeway, Suite 1120, Tampa, FL 33607.
(c) Citizenship: United States
(d) Title of Class of Securities: Common Stock, par value, $0.001 of the
Issuer.
(e) CUSIP Number: 91728510 8
Item 3. IF THIS STATEMENT IS FILED PUSUANT TO RULE 13-d-1(b), CHECK WHETHER
THE PERSON IS A:
(a)[ ] Broker or Dealer registered under Section 15 of the Act
(b)[ ] Bank as defined in section 3(a)(6) of the Act
(c)[ ] Insurance Company as defined in section 3(a)(19) of the Act
(d)[ ] Investment Company registered under section 8 of the Investment
Company Act
(e)[ ] Investment Advisor registered under section 203 of the Investment
Advisor Act of 1940
(f)[ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974
or Endowment Fund, see section 240.13d-1(b)(1)(ii)(F)
(g)[ ] Parent Holding Company, in accordance with section 240.13d-1(b)
(ii)(G)(Note: See Item 7)
(h)[ ] Group, in accordance with section 240.13d-(b)(1)(ii)(H)
Item 4. OWNERSHIP
(a) Amount Beneficially Owned: 1,078,715 shares of the Issuer's
Common Stock
<PAGE> 4
CUSIP No. 917285 10 8 Page 4 of 5 Pages
(b) Percent of Class: 9.02%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 1,078,715
(ii) shared power to vote or to direct the vote:
(iii) sole power to dispose or direct the disposition of: 1,078,715
(iv) shared power to dispose or direct the disposition of:
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more that
five percent of the class of securities, check the following [ ].
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
<PAGE> 5
CUSIP No. 917285 10 8 Page 5 of 5 Pages
Item 10.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course
of business and were not acquired for the purpose of and do not have the effect
of changing or influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any transaction
having such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
2/10/98
----------------------------------------
Date
/s/ RICHARD C. DAVIS JR.
----------------------------------------
Signature
Richard C. Davis Jr., Chairman
----------------------------------------
Name/Title
